< Back to companies

VPDesigner42™ is a powerful drug discovery platform leveraging the latest advances in computational de novo peptide design and unnatural peptide synthesis.

Only accessible to MedStartr community members. Join now

Company Info

Founded
2020
Website
www.pioligon.pl/

Categories

Drug DiscoveryBiotechAI drug discoveryDrug Development

Disease Areas

Technologies

Drug Discovery PlatformComputational Drug DiscoveryProtein DesignChemical Synthesis
Only accessible to MedStartr community members. Join now

What do you think of PioLigOn?

A HUGE part of what early stage companies, and even late stage ones, need and get on MedStartr is honest feedback from actual patients, clinicians, hospital leaders and industry insiders. It is very easy to get tunnel vision as a founder. Please tell the team that runs this company what you think.

Innovation

Clinical Benefit

Feasibility

Scalability

Only accessible to MedStartr community members. Join now